To prohibit contracting with certain biotechnology providers, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To prohibit contracting with certain biotechnology providers, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations, Technology, Defense.
Who Benefits and How
federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H49BDEB6E101C4E5393500D5C4A9D7244: 1. Short title This Act may be cited as the BIOSECURE Act.
- Section HFB7578370D68498F99182F950F1097B7: 2. Prohibition on contracting with certain biotechnology providers The head of an executive agency may not— procure or obtain any biotechnology equipment or...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To prohibit contracting with certain biotechnology providers, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.
Key Policy Areas
Government Operations, Technology, Defense
Primary Purpose
This bill, To prohibit contracting with certain biotechnology providers, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.
Policy Domains
Whole bill
Identified Gains
- federal agencies and legislative administrators
Identified Costs
- federal implementing agencies
Sponsors
Legislative Progress
In CommitteeReceived; read twice and referred to the Committee on Homeland …
Mr. Wenstrup (for himself, Mr. Krishnamoorthi, Mr. Moolenaar, Ms. Eshoo, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_defense"
- → Secretary of Defense
- "secretary_of_commerce"
- → Secretary of Commerce
- "secretary_of_homeland_security"
- → Secretary of Homeland Security
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology